Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion type Assertion NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_head.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion description "[The majority of papillomas in control mice regressed after termination of 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment, whereas p53m papillomas progressed to carcinomas and metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_provenance.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion evidence source_evidence_literature NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_provenance.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion SIO_000772 9671312 NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_provenance.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion wasDerivedFrom befree-20140225 NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_provenance.
- NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_assertion wasGeneratedBy ECO_0000203 NP293640.RAqpYv8JQMt7etX-ZaVrE01uTFi6irvzf6t23pnEjX8dE130_provenance.